nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—acquired immunodeficiency syndrome—sarcoma	0.629	1	CtDrD
Indinavir—ABCC1—Dactinomycin—sarcoma	0.0389	0.126	CbGbCtD
Indinavir—ABCC1—Mitoxantrone—sarcoma	0.0348	0.112	CbGbCtD
Indinavir—ABCC1—Epirubicin—sarcoma	0.0281	0.0909	CbGbCtD
Indinavir—ABCC1—Vincristine—sarcoma	0.0239	0.0773	CbGbCtD
Indinavir—ABCC1—Etoposide—sarcoma	0.0219	0.0709	CbGbCtD
Indinavir—ABCC2—Vincristine—sarcoma	0.0177	0.0572	CbGbCtD
Indinavir—ABCC2—Etoposide—sarcoma	0.0162	0.0524	CbGbCtD
Indinavir—ABCC1—Doxorubicin—sarcoma	0.015	0.0483	CbGbCtD
Indinavir—CYP3A7—Vincristine—sarcoma	0.0118	0.0382	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0118	0.0382	CbGbCtD
Indinavir—CYP3A4—Thiotepa—sarcoma	0.0117	0.0378	CbGbCtD
Indinavir—ABCC2—Doxorubicin—sarcoma	0.0111	0.0358	CbGbCtD
Indinavir—ABCB1—Dactinomycin—sarcoma	0.00938	0.0303	CbGbCtD
Indinavir—CYP3A5—Vincristine—sarcoma	0.00887	0.0287	CbGbCtD
Indinavir—ABCB1—Mitoxantrone—sarcoma	0.00839	0.0271	CbGbCtD
Indinavir—CYP3A5—Etoposide—sarcoma	0.00813	0.0263	CbGbCtD
Indinavir—ABCB1—Vincristine—sarcoma	0.00578	0.0187	CbGbCtD
Indinavir—ABCB1—Etoposide—sarcoma	0.00529	0.0171	CbGbCtD
Indinavir—CYP3A4—Mitoxantrone—sarcoma	0.00503	0.0162	CbGbCtD
Indinavir—ABCB1—Doxorubicin—sarcoma	0.00361	0.0117	CbGbCtD
Indinavir—CYP3A4—Vincristine—sarcoma	0.00346	0.0112	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—sarcoma	0.0034	0.011	CbGbCtD
Indinavir—CYP3A4—Etoposide—sarcoma	0.00317	0.0102	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—sarcoma	0.00216	0.00699	CbGbCtD
Indinavir—Anaphylactic shock—Etoposide—sarcoma	8.26e-05	0.00133	CcSEcCtD
Indinavir—Asthenia—Thiotepa—sarcoma	8.25e-05	0.00133	CcSEcCtD
Indinavir—Abdominal distension—Epirubicin—sarcoma	8.19e-05	0.00132	CcSEcCtD
Indinavir—Asthenia—Dactinomycin—sarcoma	8.19e-05	0.00132	CcSEcCtD
Indinavir—Feeling abnormal—Mitoxantrone—sarcoma	8.18e-05	0.00132	CcSEcCtD
Indinavir—Blood creatinine increased—Doxorubicin—sarcoma	8.16e-05	0.00132	CcSEcCtD
Indinavir—Pruritus—Thiotepa—sarcoma	8.13e-05	0.00131	CcSEcCtD
Indinavir—Gastrointestinal pain—Mitoxantrone—sarcoma	8.12e-05	0.00131	CcSEcCtD
Indinavir—Thrombocytopenia—Etoposide—sarcoma	8.09e-05	0.00131	CcSEcCtD
Indinavir—Abdominal pain—Vincristine—sarcoma	8.06e-05	0.0013	CcSEcCtD
Indinavir—Body temperature increased—Vincristine—sarcoma	8.06e-05	0.0013	CcSEcCtD
Indinavir—Skin disorder—Etoposide—sarcoma	8.02e-05	0.0013	CcSEcCtD
Indinavir—Dry skin—Doxorubicin—sarcoma	7.99e-05	0.00129	CcSEcCtD
Indinavir—Hyperhidrosis—Etoposide—sarcoma	7.98e-05	0.00129	CcSEcCtD
Indinavir—Pancreatitis—Epirubicin—sarcoma	7.98e-05	0.00129	CcSEcCtD
Indinavir—Angina pectoris—Epirubicin—sarcoma	7.93e-05	0.00128	CcSEcCtD
Indinavir—Urticaria—Mitoxantrone—sarcoma	7.89e-05	0.00127	CcSEcCtD
Indinavir—Anorexia—Etoposide—sarcoma	7.87e-05	0.00127	CcSEcCtD
Indinavir—Diarrhoea—Thiotepa—sarcoma	7.87e-05	0.00127	CcSEcCtD
Indinavir—Abdominal pain—Mitoxantrone—sarcoma	7.85e-05	0.00127	CcSEcCtD
Indinavir—Body temperature increased—Mitoxantrone—sarcoma	7.85e-05	0.00127	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	7.85e-05	0.00127	CcSEcCtD
Indinavir—Diarrhoea—Dactinomycin—sarcoma	7.81e-05	0.00126	CcSEcCtD
Indinavir—Gastritis—Doxorubicin—sarcoma	7.71e-05	0.00125	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	7.69e-05	0.00124	CcSEcCtD
Indinavir—Muscular weakness—Doxorubicin—sarcoma	7.69e-05	0.00124	CcSEcCtD
Indinavir—Dysuria—Epirubicin—sarcoma	7.61e-05	0.00123	CcSEcCtD
Indinavir—Dizziness—Thiotepa—sarcoma	7.6e-05	0.00123	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—sarcoma	7.58e-05	0.00123	CcSEcCtD
Indinavir—Upper respiratory tract infection—Epirubicin—sarcoma	7.57e-05	0.00122	CcSEcCtD
Indinavir—Pollakiuria—Epirubicin—sarcoma	7.52e-05	0.00121	CcSEcCtD
Indinavir—Hypersensitivity—Vincristine—sarcoma	7.51e-05	0.00121	CcSEcCtD
Indinavir—Paraesthesia—Etoposide—sarcoma	7.42e-05	0.0012	CcSEcCtD
Indinavir—Weight increased—Epirubicin—sarcoma	7.41e-05	0.0012	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—sarcoma	7.38e-05	0.00119	CcSEcCtD
Indinavir—Dyspnoea—Etoposide—sarcoma	7.36e-05	0.00119	CcSEcCtD
Indinavir—Hyperglycaemia—Epirubicin—sarcoma	7.34e-05	0.00119	CcSEcCtD
Indinavir—Somnolence—Etoposide—sarcoma	7.34e-05	0.00119	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—sarcoma	7.34e-05	0.00119	CcSEcCtD
Indinavir—Hypersensitivity—Mitoxantrone—sarcoma	7.31e-05	0.00118	CcSEcCtD
Indinavir—Asthenia—Vincristine—sarcoma	7.31e-05	0.00118	CcSEcCtD
Indinavir—Vomiting—Thiotepa—sarcoma	7.31e-05	0.00118	CcSEcCtD
Indinavir—Pneumonia—Epirubicin—sarcoma	7.3e-05	0.00118	CcSEcCtD
Indinavir—Vomiting—Dactinomycin—sarcoma	7.25e-05	0.00117	CcSEcCtD
Indinavir—Rash—Thiotepa—sarcoma	7.25e-05	0.00117	CcSEcCtD
Indinavir—Dermatitis—Thiotepa—sarcoma	7.24e-05	0.00117	CcSEcCtD
Indinavir—Headache—Thiotepa—sarcoma	7.2e-05	0.00116	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Epirubicin—sarcoma	7.2e-05	0.00116	CcSEcCtD
Indinavir—Rash—Dactinomycin—sarcoma	7.19e-05	0.00116	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—sarcoma	7.18e-05	0.00116	CcSEcCtD
Indinavir—Renal failure—Epirubicin—sarcoma	7.13e-05	0.00115	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—sarcoma	7.13e-05	0.00115	CcSEcCtD
Indinavir—Asthenia—Mitoxantrone—sarcoma	7.12e-05	0.00115	CcSEcCtD
Indinavir—Fatigue—Etoposide—sarcoma	7.12e-05	0.00115	CcSEcCtD
Indinavir—Neuropathy peripheral—Epirubicin—sarcoma	7.11e-05	0.00115	CcSEcCtD
Indinavir—Jaundice—Epirubicin—sarcoma	7.07e-05	0.00114	CcSEcCtD
Indinavir—Constipation—Etoposide—sarcoma	7.06e-05	0.00114	CcSEcCtD
Indinavir—Pain—Etoposide—sarcoma	7.06e-05	0.00114	CcSEcCtD
Indinavir—Urinary tract infection—Epirubicin—sarcoma	7.05e-05	0.00114	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—sarcoma	7.04e-05	0.00114	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—sarcoma	7e-05	0.00113	CcSEcCtD
Indinavir—Diarrhoea—Vincristine—sarcoma	6.97e-05	0.00113	CcSEcCtD
Indinavir—Sweating—Epirubicin—sarcoma	6.96e-05	0.00112	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—sarcoma	6.96e-05	0.00112	CcSEcCtD
Indinavir—Haematuria—Epirubicin—sarcoma	6.92e-05	0.00112	CcSEcCtD
Indinavir—Hepatobiliary disease—Epirubicin—sarcoma	6.86e-05	0.00111	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—sarcoma	6.85e-05	0.00111	CcSEcCtD
Indinavir—Nausea—Thiotepa—sarcoma	6.83e-05	0.0011	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—sarcoma	6.81e-05	0.0011	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—sarcoma	6.8e-05	0.0011	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—sarcoma	6.79e-05	0.0011	CcSEcCtD
Indinavir—Diarrhoea—Mitoxantrone—sarcoma	6.79e-05	0.0011	CcSEcCtD
Indinavir—Nausea—Dactinomycin—sarcoma	6.78e-05	0.00109	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—sarcoma	6.75e-05	0.00109	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—sarcoma	6.75e-05	0.00109	CcSEcCtD
Indinavir—Dizziness—Vincristine—sarcoma	6.74e-05	0.00109	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	6.66e-05	0.00108	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—sarcoma	6.6e-05	0.00107	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—sarcoma	6.58e-05	0.00106	CcSEcCtD
Indinavir—Urticaria—Etoposide—sarcoma	6.56e-05	0.00106	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—sarcoma	6.55e-05	0.00106	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—sarcoma	6.55e-05	0.00106	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—sarcoma	6.53e-05	0.00105	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—sarcoma	6.53e-05	0.00105	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—sarcoma	6.53e-05	0.00105	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—sarcoma	6.52e-05	0.00105	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—sarcoma	6.52e-05	0.00105	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—sarcoma	6.48e-05	0.00105	CcSEcCtD
Indinavir—Vomiting—Vincristine—sarcoma	6.48e-05	0.00105	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—sarcoma	6.47e-05	0.00104	CcSEcCtD
Indinavir—Sweating—Doxorubicin—sarcoma	6.44e-05	0.00104	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—sarcoma	6.43e-05	0.00104	CcSEcCtD
Indinavir—Rash—Vincristine—sarcoma	6.43e-05	0.00104	CcSEcCtD
Indinavir—Dermatitis—Vincristine—sarcoma	6.42e-05	0.00104	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—sarcoma	6.4e-05	0.00103	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—sarcoma	6.4e-05	0.00103	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—sarcoma	6.39e-05	0.00103	CcSEcCtD
Indinavir—Headache—Vincristine—sarcoma	6.39e-05	0.00103	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—sarcoma	6.35e-05	0.00103	CcSEcCtD
Indinavir—Vomiting—Mitoxantrone—sarcoma	6.31e-05	0.00102	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—sarcoma	6.3e-05	0.00102	CcSEcCtD
Indinavir—Rash—Mitoxantrone—sarcoma	6.26e-05	0.00101	CcSEcCtD
Indinavir—Dermatitis—Mitoxantrone—sarcoma	6.25e-05	0.00101	CcSEcCtD
Indinavir—Headache—Mitoxantrone—sarcoma	6.22e-05	0.001	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—sarcoma	6.16e-05	0.000995	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—sarcoma	6.08e-05	0.000983	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—sarcoma	6.06e-05	0.000979	CcSEcCtD
Indinavir—Nausea—Vincristine—sarcoma	6.06e-05	0.000978	CcSEcCtD
Indinavir—Flushing—Epirubicin—sarcoma	6.05e-05	0.000977	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—sarcoma	6.03e-05	0.000974	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—sarcoma	6.03e-05	0.000974	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—sarcoma	6e-05	0.000969	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—sarcoma	5.98e-05	0.000967	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—sarcoma	5.95e-05	0.000962	CcSEcCtD
Indinavir—Asthenia—Etoposide—sarcoma	5.92e-05	0.000957	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—sarcoma	5.92e-05	0.000957	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—sarcoma	5.91e-05	0.000955	CcSEcCtD
Indinavir—Nausea—Mitoxantrone—sarcoma	5.9e-05	0.000953	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—sarcoma	5.88e-05	0.000951	CcSEcCtD
Indinavir—Chills—Epirubicin—sarcoma	5.85e-05	0.000944	CcSEcCtD
Indinavir—Pruritus—Etoposide—sarcoma	5.84e-05	0.000944	CcSEcCtD
Indinavir—Alopecia—Epirubicin—sarcoma	5.76e-05	0.00093	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—sarcoma	5.7e-05	0.000921	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—sarcoma	5.67e-05	0.000916	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—sarcoma	5.65e-05	0.000913	CcSEcCtD
Indinavir—Flushing—Doxorubicin—sarcoma	5.59e-05	0.000904	CcSEcCtD
Indinavir—Flatulence—Epirubicin—sarcoma	5.59e-05	0.000903	CcSEcCtD
Indinavir—Tension—Epirubicin—sarcoma	5.57e-05	0.000899	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—sarcoma	5.55e-05	0.000897	CcSEcCtD
Indinavir—Nervousness—Epirubicin—sarcoma	5.51e-05	0.00089	CcSEcCtD
Indinavir—Back pain—Epirubicin—sarcoma	5.49e-05	0.000886	CcSEcCtD
Indinavir—Dizziness—Etoposide—sarcoma	5.46e-05	0.000882	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—sarcoma	5.45e-05	0.000881	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—sarcoma	5.45e-05	0.00088	CcSEcCtD
Indinavir—Chills—Doxorubicin—sarcoma	5.41e-05	0.000874	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—sarcoma	5.35e-05	0.000864	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—sarcoma	5.33e-05	0.000861	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—sarcoma	5.26e-05	0.00085	CcSEcCtD
Indinavir—Vomiting—Etoposide—sarcoma	5.25e-05	0.000848	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—sarcoma	5.25e-05	0.000848	CcSEcCtD
Indinavir—Anaemia—Epirubicin—sarcoma	5.24e-05	0.000847	CcSEcCtD
Indinavir—Agitation—Epirubicin—sarcoma	5.21e-05	0.000842	CcSEcCtD
Indinavir—Rash—Etoposide—sarcoma	5.21e-05	0.000841	CcSEcCtD
Indinavir—Dermatitis—Etoposide—sarcoma	5.2e-05	0.00084	CcSEcCtD
Indinavir—Headache—Etoposide—sarcoma	5.17e-05	0.000836	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—sarcoma	5.17e-05	0.000835	CcSEcCtD
Indinavir—Tension—Doxorubicin—sarcoma	5.15e-05	0.000832	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—sarcoma	5.14e-05	0.00083	CcSEcCtD
Indinavir—Malaise—Epirubicin—sarcoma	5.11e-05	0.000826	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—sarcoma	5.1e-05	0.000823	CcSEcCtD
Indinavir—Vertigo—Epirubicin—sarcoma	5.1e-05	0.000823	CcSEcCtD
Indinavir—Syncope—Epirubicin—sarcoma	5.09e-05	0.000822	CcSEcCtD
Indinavir—Back pain—Doxorubicin—sarcoma	5.08e-05	0.00082	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—sarcoma	5.05e-05	0.000815	CcSEcCtD
Indinavir—Palpitations—Epirubicin—sarcoma	5.01e-05	0.00081	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—sarcoma	4.98e-05	0.000805	CcSEcCtD
Indinavir—Cough—Epirubicin—sarcoma	4.95e-05	0.0008	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—sarcoma	4.95e-05	0.000799	CcSEcCtD
Indinavir—Nausea—Etoposide—sarcoma	4.91e-05	0.000792	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—sarcoma	4.87e-05	0.000787	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—sarcoma	4.85e-05	0.000784	CcSEcCtD
Indinavir—Myalgia—Epirubicin—sarcoma	4.83e-05	0.00078	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—sarcoma	4.83e-05	0.00078	CcSEcCtD
Indinavir—Chest pain—Epirubicin—sarcoma	4.83e-05	0.00078	CcSEcCtD
Indinavir—Agitation—Doxorubicin—sarcoma	4.82e-05	0.000779	CcSEcCtD
Indinavir—Anxiety—Epirubicin—sarcoma	4.81e-05	0.000777	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	4.8e-05	0.000775	CcSEcCtD
Indinavir—Discomfort—Epirubicin—sarcoma	4.77e-05	0.000771	CcSEcCtD
Indinavir—Malaise—Doxorubicin—sarcoma	4.73e-05	0.000765	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—sarcoma	4.72e-05	0.000763	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—sarcoma	4.71e-05	0.000762	CcSEcCtD
Indinavir—Syncope—Doxorubicin—sarcoma	4.71e-05	0.00076	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—sarcoma	4.64e-05	0.000749	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—sarcoma	4.63e-05	0.000748	CcSEcCtD
Indinavir—Oedema—Epirubicin—sarcoma	4.63e-05	0.000748	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—sarcoma	4.61e-05	0.000745	CcSEcCtD
Indinavir—Cough—Doxorubicin—sarcoma	4.58e-05	0.00074	CcSEcCtD
Indinavir—Shock—Epirubicin—sarcoma	4.55e-05	0.000736	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—sarcoma	4.54e-05	0.000733	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—sarcoma	4.53e-05	0.000732	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—sarcoma	4.5e-05	0.000726	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—sarcoma	4.47e-05	0.000723	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—sarcoma	4.47e-05	0.000722	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—sarcoma	4.47e-05	0.000722	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—sarcoma	4.47e-05	0.000722	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—sarcoma	4.45e-05	0.000719	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	4.44e-05	0.000717	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—sarcoma	4.41e-05	0.000713	CcSEcCtD
Indinavir—Anorexia—Epirubicin—sarcoma	4.41e-05	0.000713	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—sarcoma	4.37e-05	0.000706	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—sarcoma	4.28e-05	0.000692	CcSEcCtD
Indinavir—Oedema—Doxorubicin—sarcoma	4.28e-05	0.000692	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—sarcoma	4.22e-05	0.000681	CcSEcCtD
Indinavir—Shock—Doxorubicin—sarcoma	4.21e-05	0.000681	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—sarcoma	4.2e-05	0.000679	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—sarcoma	4.19e-05	0.000678	CcSEcCtD
Indinavir—Insomnia—Epirubicin—sarcoma	4.19e-05	0.000676	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—sarcoma	4.16e-05	0.000672	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—sarcoma	4.16e-05	0.000672	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—sarcoma	4.14e-05	0.000669	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—sarcoma	4.13e-05	0.000667	CcSEcCtD
Indinavir—Somnolence—Epirubicin—sarcoma	4.12e-05	0.000665	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—sarcoma	4.08e-05	0.00066	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—sarcoma	4.07e-05	0.000658	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—sarcoma	4.02e-05	0.00065	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—sarcoma	4e-05	0.000646	CcSEcCtD
Indinavir—Fatigue—Epirubicin—sarcoma	3.99e-05	0.000645	CcSEcCtD
Indinavir—Pain—Epirubicin—sarcoma	3.96e-05	0.00064	CcSEcCtD
Indinavir—Constipation—Epirubicin—sarcoma	3.96e-05	0.00064	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.9e-05	0.00063	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—sarcoma	3.87e-05	0.000626	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—sarcoma	3.85e-05	0.000621	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—sarcoma	3.82e-05	0.000617	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—sarcoma	3.81e-05	0.000616	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—sarcoma	3.81e-05	0.000615	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—sarcoma	3.79e-05	0.000612	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—sarcoma	3.77e-05	0.000609	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—sarcoma	3.72e-05	0.000602	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—sarcoma	3.7e-05	0.000597	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—sarcoma	3.69e-05	0.000597	CcSEcCtD
Indinavir—Urticaria—Epirubicin—sarcoma	3.68e-05	0.000594	CcSEcCtD
Indinavir—Pain—Doxorubicin—sarcoma	3.66e-05	0.000592	CcSEcCtD
Indinavir—Constipation—Doxorubicin—sarcoma	3.66e-05	0.000592	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—sarcoma	3.66e-05	0.000591	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—sarcoma	3.66e-05	0.000591	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—sarcoma	3.53e-05	0.00057	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—sarcoma	3.5e-05	0.000566	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—sarcoma	3.41e-05	0.000551	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—sarcoma	3.4e-05	0.00055	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—sarcoma	3.39e-05	0.000547	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—sarcoma	3.39e-05	0.000547	CcSEcCtD
Indinavir—Asthenia—Epirubicin—sarcoma	3.32e-05	0.000537	CcSEcCtD
Indinavir—Pruritus—Epirubicin—sarcoma	3.27e-05	0.000529	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—sarcoma	3.17e-05	0.000512	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—sarcoma	3.16e-05	0.00051	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—sarcoma	3.07e-05	0.000496	CcSEcCtD
Indinavir—Dizziness—Epirubicin—sarcoma	3.06e-05	0.000495	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—sarcoma	3.03e-05	0.00049	CcSEcCtD
Indinavir—Vomiting—Epirubicin—sarcoma	2.94e-05	0.000475	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—sarcoma	2.93e-05	0.000473	CcSEcCtD
Indinavir—Rash—Epirubicin—sarcoma	2.92e-05	0.000472	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—sarcoma	2.92e-05	0.000471	CcSEcCtD
Indinavir—Headache—Epirubicin—sarcoma	2.9e-05	0.000469	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—sarcoma	2.83e-05	0.000458	CcSEcCtD
Indinavir—Nausea—Epirubicin—sarcoma	2.75e-05	0.000444	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—sarcoma	2.72e-05	0.00044	CcSEcCtD
Indinavir—Rash—Doxorubicin—sarcoma	2.7e-05	0.000436	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—sarcoma	2.7e-05	0.000436	CcSEcCtD
Indinavir—Headache—Doxorubicin—sarcoma	2.68e-05	0.000433	CcSEcCtD
Indinavir—Nausea—Doxorubicin—sarcoma	2.54e-05	0.000411	CcSEcCtD
